Mouse cardiac acyl coenzyme a synthetase 1 deficiency impairs Fatty Acid oxidation and induces cardiac hypertrophy.
about
Remodeling of glucose metabolism precedes pressure overload-induced left ventricular hypertrophy: review of a hypothesis.Lipids and the endothelium: bidirectional interactionsSRC-2 coactivator deficiency decreases functional reserve in response to pressure overload of mouse heartAdipose fatty acid oxidation is required for thermogenesis and potentiates oxidative stress-induced inflammationAcyl coenzyme A synthetase long-chain 1 (ACSL1) gene polymorphism (rs6552828) and elite endurance athletic status: a replication studyGenetic association of long-chain acyl-CoA synthetase 1 variants with fasting glucose, diabetes, and subclinical atherosclerosisGlucose regulation of load-induced mTOR signaling and ER stress in mammalian heart.Relationship of glucose and oleate metabolism to cardiac function in lipin-1 deficient (fld) miceDeficiency of cardiac Acyl-CoA synthetase-1 induces diastolic dysfunction, but pathologic hypertrophy is reversed by rapamycinLower Expression of SLC27A1 Enhances Intramuscular Fat Deposition in Chicken via Down-Regulated Fatty Acid Oxidation Mediated by CPT1A.Deficiency of a lipid droplet protein, perilipin 5, suppresses myocardial lipid accumulation, thereby preventing type 1 diabetes-induced heart malfunctionCardiac-specific inhibition of kinase activity in calcium/calmodulin-dependent protein kinase kinase-β leads to accelerated left ventricular remodeling and heart failure after transverse aortic constriction in mice.Compartmentalized acyl-CoA metabolism in skeletal muscle regulates systemic glucose homeostasisMetabolic and tissue-specific regulation of acyl-CoA metabolism.Re-patterning of skeletal muscle energy metabolism by fat storage-inducing transmembrane protein 2.Uncomplicating the Macrovascular Complications of Diabetes: The 2014 Edwin Bierman Award LectureAcyl-CoA synthetase 1 deficiency alters cardiolipin species and impairs mitochondrial function.Quantitative proteomics analysis reveals glutamine deprivation activates fatty acid β-oxidation pathway in HepG2 cells.Physiological Consequences of Compartmentalized Acyl-CoA Metabolism.Mouse betaine-homocysteine S-methyltransferase deficiency reduces body fat via increasing energy expenditure and impairing lipid synthesis and enhancing glucose oxidation in white adipose tissueSystematic Analysis of Gene Expression Alterations and Clinical Outcomes for Long-Chain Acyl-Coenzyme A Synthetase Family in Cancer.Genetic modifiers of response to glucose-insulin-potassium (GIK) infusion in acute coronary syndromes and associations with clinical outcomes in the IMMEDIATE trial.Loss of long-chain acyl-CoA synthetase isoform 1 impairs cardiac autophagy and mitochondrial structure through mechanistic target of rapamycin complex 1 activation.IL-1β reciprocally regulates chemokine and insulin secretion in pancreatic β-cells via NF-κB.Quantitative analysis of the murine lipid droplet-associated proteome during diet-induced hepatic steatosis.Characterization of the promoter region of the bovine long-chain acyl-CoA synthetase 1 gene: Roles of E2F1, Sp1, KLF15, and E2F4.Endothelial acyl-CoA synthetase 1 is not required for inflammatory and apoptotic effects of a saturated fatty acid-rich environment.SREBP2 Activation Induces Hepatic Long-chain Acyl-CoA Synthetase 1 (ACSL1) Expression in Vivo and in Vitro through a Sterol Regulatory Element (SRE) Motif of the ACSL1 C-promoter.Acyl-CoA synthetase 1 is induced by Gram-negative bacteria and lipopolysaccharide and is required for phospholipid turnover in stimulated macrophages.High-fructose diet downregulates long-chain acyl-CoA synthetase 3 expression in liver of hamsters via impairing LXR/RXR signaling pathway.Acyl CoA synthetase-1 links facilitated long chain fatty acid uptake to intracellular metabolic trafficking differently in hearts of male versus female mice.Endogenous and Synthetic ABHD5 Ligands Regulate ABHD5-Perilipin Interactions and Lipolysis in Fat and Muscle.Diminished acyl-CoA synthetase isoform 4 activity in INS 832/13 cells reduces cellular epoxyeicosatrienoic acid levels and results in impaired glucose-stimulated insulin secretion.Phosphorylation and Acetylation of Acyl-CoA Synthetase- IHepatic fatty acid trafficking: multiple forks in the roadLipotoxic disruption of NHE1 interaction with PI(4,5)P2 expedites proximal tubule apoptosis.Multipronged Therapeutic Effects of Chinese Herbal Medicine Qishenyiqi in the Treatment of Acute Myocardial InfarctionLipid metabolism and toxicity in the heart.Inflammation and diabetes-accelerated atherosclerosis: myeloid cell mediators.Intestinal acyl-CoA synthetase 5: activation of long chain fatty acids and behind.
P2860
Q26853332-5ED14207-EEED-4890-8BE1-F65BFB06B766Q26860086-3BC28658-3F65-4829-B579-4B7FFD41BBA9Q27321625-4B557615-D0B0-4C29-87BC-BCE93E11C0F9Q28255284-65175F19-764F-4020-A5F9-82703355D613Q28729031-C73DDC32-A669-491B-99D6-BB62F0F638C8Q30277854-9A8235E9-0EB6-4C11-8147-5B068FC6CDB6Q30417331-DD14F5A7-EE10-4539-9387-FFB9D01D8580Q30423169-56D63CAC-91D9-4461-A40F-1F91DE9A6AF1Q33719493-D15745DE-371B-45FF-8B0E-77817F95B76AQ33849841-177CB6D1-2630-449A-A5BB-D75C6280DAEFQ33899819-C0643C02-D277-4DF8-B9E2-9B416386C163Q34257348-50D3F0CF-2969-4992-B800-C2709CA45527Q34762456-44C056DB-4595-4EA6-B5E8-3FD58B7063D6Q35168513-2720D8AA-613D-4F80-B910-1F6DFB750CADQ35604994-AFF535DF-DF25-4373-95BB-27AE8D7BC35BQ35881759-8BE71E3B-B3ED-4327-A7DB-2BA4970275F6Q35886303-1B2646AF-0164-4D78-BAFC-7C99EAD71CA0Q35912447-77DF5CC4-B667-43CB-AF9A-2CCC9195672CQ35953045-D01BBF0B-2517-4A2F-B723-B55A20A620F9Q35956425-1A417B95-1CD4-4B3B-97C6-9B8FE2CD396DQ36015852-64697829-14BF-4002-9801-7846CB016A10Q36070345-3704EF57-A691-458A-8916-C50DFA4B1E60Q36171264-CE451F2D-A207-4420-8FC8-5EA2151BDAFFQ36174390-7BB33461-C01D-4257-98E9-04C956134DCCQ36307276-4FF435D1-9E62-44A6-81A5-9704256A0D0AQ36499984-218EF49D-CD72-43A0-916E-D70AE3D64033Q36558881-08850F87-FE1B-450D-97F5-76B2802FAA52Q36650405-F1E7520D-AF04-4FAF-9078-3F4BC480529BQ36742281-E87B10E1-E6ED-4347-BBB8-5376305DF340Q36754794-10977F37-6B29-4D32-BDC1-5BFE05028AD6Q36885497-7DB037A4-DDBC-48D6-9CD2-082FCD2D9BF9Q36886505-95BAE463-24B0-46C1-8AF6-A7B2DDE9B303Q37048349-8A628AFC-B168-4BA8-9DE4-8A4E466DBDCEQ37170087-DB534FDA-92AF-420D-AF35-A3BE7784946EQ37296476-3EFF2BC6-4C64-4EEC-9437-DB7DF04446D9Q37602179-F121F839-965B-4C04-A092-4AE9428B30ABQ37675420-580DA692-AF0A-4940-80AF-2E0777E91250Q38017379-D63F8E8B-E5AE-4130-9DCC-50EC8B57A886Q38059912-2E7CCFEB-C489-41E0-83F2-DB1C76318113Q38164704-99F33953-D5A3-40E2-9E02-AA0843C16DFC
P2860
Mouse cardiac acyl coenzyme a synthetase 1 deficiency impairs Fatty Acid oxidation and induces cardiac hypertrophy.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
Mouse cardiac acyl coenzyme a ...... d induces cardiac hypertrophy.
@ast
Mouse cardiac acyl coenzyme a ...... d induces cardiac hypertrophy.
@en
Mouse cardiac acyl coenzyme a ...... d induces cardiac hypertrophy.
@nl
type
label
Mouse cardiac acyl coenzyme a ...... d induces cardiac hypertrophy.
@ast
Mouse cardiac acyl coenzyme a ...... d induces cardiac hypertrophy.
@en
Mouse cardiac acyl coenzyme a ...... d induces cardiac hypertrophy.
@nl
prefLabel
Mouse cardiac acyl coenzyme a ...... d induces cardiac hypertrophy.
@ast
Mouse cardiac acyl coenzyme a ...... d induces cardiac hypertrophy.
@en
Mouse cardiac acyl coenzyme a ...... d induces cardiac hypertrophy.
@nl
P2093
P2860
P50
P356
P1476
Mouse cardiac acyl coenzyme a ...... d induces cardiac hypertrophy.
@en
P2093
Gary W Cline
Heinrich Taegtmeyer
Jessica M Ellis
Michael A Depetrillo
Rosalind A Coleman
Shannon M Mentock
Shiraj Sen
Steven M Watkins
Timothy R Koves
P2860
P304
P356
10.1128/MCB.01085-10
P407
P577
2011-01-18T00:00:00Z